June 22, 2022

Why Shares of BeiGene Popped Today

What happened
BeiGene’s (NASDAQ: BGNE) shares were up by more than 13% on Tuesday at 2:50 p.m. ET thanks to a regulatory body in China accepting one of the company’s supplemental biologics licensing application filings for a new indication for its drug tislelizumab.

This post was originally published on this site

Sign Up To Get FREE News, Tips and Offers!